Compare Invesco S&P 500 High Div Low Volatility ETF (SPHD) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco S&P 500 High Div Low Volatility ETF vs GeneDx Holdings Corp — how do they compare? Invesco S&P 500 High Div Low Volatility ETF trades at $48.82 (market cap $3.14B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Invesco S&P 500 High Div Low Volatility ETF is the larger of the two by market cap, and GeneDx Holdings Corp is more actively traded (734,640 versus 1,461,349). Which is the better fit depends on your goals — on Pluang, investors hold Invesco S&P 500 High Div Low Volatility ETF for 125 Days and GeneDx Holdings Corp for 19 Days on average.
| SPHD | WGS | |
|---|---|---|
Market Cap | $3.14B | $2.02B |
Volume | 1,461,349 | 734,640 |
52-Week High | $53.55 | $167.51 |
52-Week Low | $46.96 | $34.51 |
Typical Hold Time | 125 Days | 19 Days |
Sector | — | Health |
Enterprise Value | — | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPHD trades at $48.81, up 1.29% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF focuses on high-dividend, low-volatility S&P 500 stocks, offering monthly income, but financial ratios are not disclosed in the provided data. Recent news highlights its role in retirement income strategies, though some analysts favor competitors like SCHD for total returns.
Outlook: SPHD appeals for steady dividend income amid market volatility, but risks include underperformance versus peers and sensitivity to interest rate changes. Investors should weigh the trade-off between yield and growth potential.
GeneDx (WGS) trades at $67.73, down 1.17% today, showing mixed signals with bearish technical indicators but strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating expectations, and returned to adjusted profitability early. However, 2026 fundamentals show concerning trends with a net loss of $106 million and negative profit margins. Recent news highlights product innovations and leadership recognition, while technical analysis indicates the stock is trading near key support at $66.
The investment outlook presents a dichotomy between strong analyst conviction (90.9% buy ratings, $81 consensus target) and challenging fundamentals. While operational improvements and genomic testing growth offer potential upside, persistent losses and negative cash flow trends create significant execution risk. The stock's current position near support levels combined with oversold RSI readings suggests potential for near-term bounce, but sustainable gains require meaningful profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
